Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 57505
Gene Symbol: AARS2
AARS2
0.100 Biomarker phenotype HPO
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.020 AlteredExpression phenotype BEFREE Consistent with H-ABC's clinical presentation, TUBB4A is highly expressed in neurons, and a recent report has shown that an N-terminal alteration is associated with a heritable dystonia. 23582646 2013
Entrez Id: 10058
Gene Symbol: ABCB6
ABCB6
0.020 Biomarker phenotype BEFREE While several follow-up studies confirmed the importance of TUBB4A mutations in the development of H-ABC, their contribution to isolated dystonia remains uncertain. 26318963 2015
Entrez Id: 55331
Gene Symbol: ACER3
ACER3
0.100 Biomarker phenotype HPO
Entrez Id: 51
Gene Symbol: ACOX1
ACOX1
0.100 Biomarker phenotype HPO
Entrez Id: 197322
Gene Symbol: ACSF3
ACSF3
0.100 Biomarker phenotype HPO
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.320 Biomarker phenotype CTD_human A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. 16685646 2006
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.320 GeneticVariation phenotype BEFREE ACTB p.Arg183Trp heterozygosity has been reported in six patients to cause combined infant-onset deafness and dystonia manifesting in adolescence or young adulthood. 29788902 2018
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.320 GeneticVariation phenotype BEFREE A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. 16685646 2006
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.320 GeneticVariation phenotype LHGDN A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. 16685646 2006
Entrez Id: 95
Gene Symbol: ACY1
ACY1
0.010 Biomarker phenotype BEFREE Our report extends the clinical spectrum of ACY1 deficiency to include dystonia and indicates that screening for organic acidurias deserves consideration in patients with unexplained generalized dystonia. 26686503 2016
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 Biomarker phenotype GENOMICS_ENGLAND Mutations in ADAR1, IFIH1, and RNASEH2B presenting as spastic paraplegia. 25243380 2014
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 Biomarker phenotype GENOMICS_ENGLAND Bilateral striatal necrosis caused by ADAR mutations in two siblings with dystonia and freckles-like skin changes that should be differentiated from Leigh syndrome. 28139822 2016
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 Biomarker phenotype HPO
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 Biomarker phenotype GENOMICS_ENGLAND Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. 23001123 2012
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 Biomarker phenotype BEFREE ADAR1-related disease should be considered in the differential diagnosis of apparently non-syndromic BSN with severe dystonia of varying evolution. 24262145 2014
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 GeneticVariation phenotype BEFREE Aberrant interferon expression occurs in patients in whom ADAR1 mutations cause Aicardi-Goutières syndrome (AGS) or dystonia arising from striatal neurodegeneration. 25456137 2014
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 GeneticVariation phenotype BEFREE Bilateral striatal necrosis caused by ADAR mutations in two siblings with dystonia and freckles-like skin changes that should be differentiated from Leigh syndrome. 28139822 2016
Entrez Id: 103
Gene Symbol: ADAR
ADAR
0.440 GeneticVariation phenotype BEFREE The observations in our family raise the possibility that the ADAR1 mutation might be a direct cause or a predisposing factor for heredodegenerative dystonia. 16817193 2006
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.470 GeneticVariation phenotype BEFREE Mutations in the adenylate cyclase 5 (ADCY5) gene recently have been identified as the cause of a childhood-onset disorder characterized by persistent or paroxysmal choreic, myoclonic, and/or dystonic movements. 27931826 2017
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.470 GeneticVariation phenotype BEFREE We performed a screening of the entire ADCY5 coding sequence in 44 unrelated subjects with genetically undiagnosed childhood-onset hyperkinetic movement disorders, featuring chorea alone or in combination with myoclonus and dystonia. 28511835 2017
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.470 Biomarker phenotype BEFREE Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series. 27052971 2016
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.470 GeneticVariation phenotype BEFREE To identify the cause of childhood onset involuntary paroxysmal choreiform and dystonic movements in 2 unrelated sporadic cases and to investigate the functional effect of missense mutations in adenylyl cyclase 5 (ADCY5) in sporadic and inherited cases of autosomal dominant familial dyskinesia with facial myokymia (FDFM). 24700542 2014
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.470 GeneticVariation phenotype BEFREE Adenylyl cyclase 5 (ADCY5) mutations is associated with heterogenous syndromes: familial dyskinesia and facial myokymia; paroxysmal chorea and dystonia; autosomal-dominant chorea and dystonia; and benign hereditary chorea. 27061943 2016
Entrez Id: 111
Gene Symbol: ADCY5
ADCY5
0.470 GeneticVariation phenotype BEFREE Whole exome sequencing in a three-generation family affected with autosomal dominant chorea associated with dystonia identified a single de novo mutation—c.2088+1G>A in a 5' donor splice-site of ADCY5—segregating with the disease. 25545163 2015